• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Infect Dis . The differential demographic pattern of coronavirus disease 2019 fatality outside Hubei and from six hospitals in Hubei, China: a

tetano

Editor, Senior Moderator
BMC Infect Dis


. 2021 May 26;21(1):481.
doi: 10.1186/s12879-021-06187-4.
The differential demographic pattern of coronavirus disease 2019 fatality outside Hubei and from six hospitals in Hubei, China: a descriptive analysis


Qing-Bin Lu[SUP] #[/SUP][SUP] 1 [/SUP], Hai-Yang Zhang[SUP] #[/SUP][SUP] 2 [/SUP], Tian-Le Che[SUP] 2 [/SUP], Han Zhao[SUP] 3 [/SUP], Xi Chen[SUP] 4 [/SUP], Rui Li[SUP] 5 6 [/SUP], Wan-Li Jiang[SUP] 7 [/SUP], Hao-Long Zeng[SUP] 8 [/SUP], Xiao-Ai Zhang[SUP] 2 [/SUP], Hui Long[SUP] 9 [/SUP], Qiang Wang[SUP] 10 [/SUP], Ming-Qing Wu[SUP] 9 10 [/SUP], Michael P Ward[SUP] 11 [/SUP], Yue Chen[SUP] 12 [/SUP], Zhi-Jie Zhang[SUP] 13 [/SUP], Yang Yang[SUP] 14 [/SUP], Li-Qun Fang[SUP] 15 [/SUP], Wei Liu[SUP] 16 [/SUP]



Affiliations

Abstract

Background: The coronavirus disease 2019 (COVID-19) epidemic has been largely controlled in China, to the point where case fatality rate (CFR) data can be comprehensively evaluated.
Methods: Data on confirmed patients, with a final outcome reported as of 29 March 2020, were obtained from official websites and other internet sources. The hospitalized CFR (HCFR) was estimated, epidemiological features described, and risk factors for a fatal outcome identified.
Results: The overall HCFR in China was estimated to be 4.6% (95% CI 4.5-4.8%, P < 0.001). It increased with age and was higher in males than females. Although the highest HCFR observed was in male patients ≥70 years old, the relative risks for death outcome by sex varied across age groups, and the greatest HCFR risk ratio for males vs. females was shown in the age group of 50-60 years, higher than age groups of 60-70 and ≥ 70 years. Differential age/sex HCFR patterns across geographical regions were found: the age effect on HCFR was greater in other provinces outside Hubei than in Wuhan. An effect of longer interval from symptom onset to admission was only observed outside Hubei, not in Wuhan. By performing multivariate analysis and survival analysis, the higher HCFR was associated with older age (both P < 0.001), and male sex (both P < 0.001). Only in regions outside Hubei, longer interval from symptom onset to admission, were associated with higher HCFR.
Conclusions: This up-to-date and comprehensive picture of COVID-19 HCFR and its drivers will help healthcare givers target limited medical resources to patients with high risk of fatality.

Keywords: COVID-19; Case fatality rate; China.
 
Back
Top Bottom